Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Novartis
Novartis
Kivu Bioscience Inc.
FindCure Biosciences (ZhongShan) Co., Ltd.
Hoffmann-La Roche
Bayer
ViroMissile, Inc.
Angiex, Inc.
MacroGenics
Avacta Life Sciences Ltd
Adela, Inc
Eli Lilly and Company
Var2 Pharmaceuticals
Tanabe Pharma America, Inc.
Stella Pharma Corporation
Bayer
Actym Therapeutics, Inc.
AVM Biotechnology Inc
Pfizer
Travera Inc
Eli Lilly and Company
Eli Lilly and Company
Baxter Healthcare Corporation
Tempus AI
Elevation Oncology
Labcorp Corporation of America Holdings, Inc
Intensity Therapeutics, Inc.
BostonGene
Cybrexa Therapeutics
Cyteir Therapeutics, Inc.
Actuate Therapeutics Inc.
Shanghai PerHum Therapeutics Co., Ltd.
Prelude Therapeutics
DNAtrix, Inc.
Cellestia Biotech AG
Corvus Pharmaceuticals, Inc.
Prelude Therapeutics
Pfizer
pharmaand GmbH
Kineta Inc.
Shanghai Yunying Medical Technology
Shanghai Yunying Medical Technology
Pfizer
Prelude Therapeutics
Quadriga Biosciences, Inc.
Genzada Pharmaceuticals USA, Inc.
ImmVira Pharma Co. Ltd
Philogen S.p.A.
MacroGenics
NKGen Biotech, Inc.
SpeciCare